Literature DB >> 26759253

Is Pulmonary non-Tuberculous Mycobacterial Disease Linked with a High Burden of Latent Cytomegalovirus?

Fathiah S Amran1, Kyungchul Kim1, Andrew Lim1, Rachel Thomson2,3, Silvia Lee4, Grant Waterer5, Patricia Price6,7.   

Abstract

Cytomegalovirus (CMV) establishes lifelong infections with episodes of active replication. We hypothesized that recurrent CMV replication in older individuals may suppress protective immune responses to non-tuberculous mycobacteria (NTM) and so potentiate pulmonary disease. Accordingly, levels of antibodies to three CMV antigen preparations were higher in NTM patients than in age-matched controls. This did not reflect broad-spectrum B cell activation as total immunoglobulin levels were not equivalently increased.

Entities:  

Keywords:  Cytomegalovirus; immunosuppression; non-tuberculous mycobacteria

Mesh：

Substances：

Year:  2016        PMID： 26759253     DOI： 10.1007/s10875-016-0233-1

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


  18 in total

1.  Immune activation in patients infected with HIV type 1 and maintaining suppression of viral replication by highly active antiretroviral therapy.

Authors:  Coral-Ann M Almeida; Patricia Price; Martyn A H French
Journal:  AIDS Res Hum Retroviruses       Date:  2002-12-10       Impact factor: 2.205

Review 2.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

3.  Cytomegalovirus-specific antibodies to an immediate early antigen and a late membrane antigen and their possible role in controlling secondary cytomegalovirus infection.

Authors:  J van Zanten; M van der Giessen; L H van der Voort; W J van Son; W van der Bij; T H The
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

4.  Infection: the interferon paradox.

Authors:  Maria Papatriantafyllou
Journal:  Nat Rev Immunol       Date:  2013-05-07       Impact factor: 53.106

5.  Levels of anti-cytokine antibodies may be elevated in patients with pulmonary disease associated with non-tuberculous mycobacteria.

Authors:  Kyungchul Kim; Grant Waterer; Rachel Thomson; Ian A Yang; Najla Nashi; Dino B A Tan; Patricia Price
Journal:  Cytokine       Date:  2014-02-06       Impact factor: 3.861

6.  Effect of age and CMV on NK cell subpopulations.

Authors:  Carmen Campos; Alejandra Pera; Beatriz Sanchez-Correa; Corona Alonso; Isabel Lopez-Fernandez; Sara Morgado; Raquel Tarazona; Rafael Solana
Journal:  Exp Gerontol       Date:  2014-01-17       Impact factor: 4.032

7.  Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10.

Authors:  Juliet V Spencer; Kristen M Lockridge; Peter A Barry; Gaofeng Lin; Monica Tsang; Mark E T Penfold; Thomas J Schall
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

8.  Susceptibility to pulmonary disease due to Mycobacterium avium-intracellulare complex may reflect low IL-17 and high IL-10 responses rather than Th1 deficiency.

Authors:  Andrew Lim; Caris Allison; Patricia Price; Grant Waterer
Journal:  Clin Immunol       Date:  2010-08-24       Impact factor: 3.969

9.  IgG regulates the CD1 expression profile and lipid antigen-presenting function in human dendritic cells via FcgammaRIIa.

Authors:  Anna Smed-Sörensen; Markus Moll; Tan-Yun Cheng; Karin Loré; Anna-Carin Norlin; Leif Perbeck; D Branch Moody; Anna-Lena Spetz; Johan K Sandberg
Journal:  Blood       Date:  2008-03-12       Impact factor: 22.113

10.  Changing epidemiology of pulmonary nontuberculous mycobacteria infections.

Authors:  Rachel M Thomson
Journal:  Emerg Infect Dis       Date:  2010-10       Impact factor: 6.883
View more
  5 in total

1.  Tissue-localized immune responses in people with cystic fibrosis and respiratory nontuberculous mycobacteria infection.

Authors:  Don Hayes; Rajni Kant Shukla; Yizi Cheng; Emrah Gecili; Marlena R Merling; Rhonda D Szczesniak; Assem G Ziady; Jason C Woods; Luanne Hall-Stoodley; Namal Pm Liyanage; Richard T Robinson
Journal:  JCI Insight       Date:  2022-06-22

2.  A high burden of cytomegalovirus marks poor vascular health in transplant recipients more clearly than in the general population.

Authors:  Silvia Lee; Emily Brook; Jacquita Affandi; Prue Howson; Selita Agnes Tanudjaja; Satvinder Dhaliwal; Ashley Irish; Patricia Price
Journal:  Clin Transl Immunology       Date:  2019-02-11

Review 3.  Immunological Aspects of Diagnosis and Management of Childhood Tuberculosis.

Authors:  Luis Horacio Gutiérrez-González; Esmeralda Juárez; Claudia Carranza; Laura E Carreto-Binaghi; Alejandro Alejandre; Carlos Cabello-Gutiérrrez; Yolanda Gonzalez
Journal:  Infect Drug Resist       Date:  2021-03-08       Impact factor: 4.003

Review 4.  Understanding the interaction between cytomegalovirus and tuberculosis in children: The way forward.

Authors:  Laura Olbrich; Lisa Stockdale; Robindra Basu Roy; Rinn Song; Luka Cicin-Sain; Elizabeth Whittaker; Andrew J Prendergast; Helen Fletcher; James A Seddon
Journal:  PLoS Pathog       Date:  2021-12-09       Impact factor: 6.823

Review 5.  A systematic review of the impact of psychosocial factors on immunity: Implications for enhancing BCG response against tuberculosis.

Authors:  Sally E Hayward; Jennifer B Dowd; Helen Fletcher; Laura B Nellums; Fatima Wurie; Delia Boccia
Journal:  SSM Popul Health       Date:  2019-11-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.